New research has shown abnormalities in the tiny blood vessels of human hearts in regions well beyond the large arteries with atherosclerotic blockages that trigger the need for stents or bypass surgery. The findings could lead to the development of new treatments for patients with angina-like symptoms without blockages or those recovering from a heart attack or unexplained heart failure.
A new study by researchers from the University of Bristol could help to improve the efficiency of surgery and tackle the growing backlog of surgery caused by the COVID-19 pandemic.
In late December 2019, a cluster of unusual pneumonia cases - now known to be the first human cases of COVID-19 - were reported in Wuhan, China. Thanks to the quick action of an Oxford scientist and her team, work on the response to the new virus began. Members of the public have the opportunity to hear the story of the Oxford AstraZeneca COVID-19 vaccine at a free online event next month.
The National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC), a partnership between the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will host intern Angel Obierozie this summer as part of the Health Data Research UK (HDR UK) programme to tackle the underrepresentation of Black people in science.
Chronic stress is a well-known cause for mental health disorders. New research has moved a step forward in understanding how glucocorticoid hormones ('stress hormones') act upon the brain and what their function is. The findings could lead to more effective strategies in the prevention and treatment of mental health disorders.
This Parkinson's disease awareness week [10-16 April], researchers at the Royal United Hospitals Bath NHS Foundation Trust and the University of Bristol are looking to recruit more patients to take part in a number of studies they run in the field of Parkinson's disease.
An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.
People with Alzheimer's disease are already helping with a ground-breaking government-funded trial led by academics from the Universities of Bristol, Cambridge, Queen's University Belfast and University College London, and hosted by North Bristol NHS Trust, but even more people are needed to take part in the study.
Emerging evidence indicates that many currently defined aerosol generating procedures (AGPs) are unlikely to play any significant role in the generation of infectious aerosol that poses a risk to hospital staff. In a comment article published in The Lancet Respiratory Medicine today [6 May] a research team from the University of Bristol discusses AGPs and the transmission of SARS-CoV-2 in a healthcare setting.
A University of Bristol researcher whose own family has been affected by diabetes has just been awarded £587,237 from leading charity Diabetes UK to find out why people with Type 2 diabetes are more likely to develop some cancers.
